Responses to parliamentary questions
Question from Deputy Michael Collins - PQ 45320-26
Deputy Collins asked for an update on the funding for the drug dupixent (dupilumab) for adults with eosinophilic oesophagitis. Read the HSE response.
From: Communications and public affairs
Published: June 2026
Updated: July 2026
Documents
Summary
To ask the Minister for Health the reason the HSE has not yet approved funding for the drug dupixent (dupilumab) for adults with eosinophilic oesophagitis; the stage the pricing and assessment process is currently at; when a decision is expected; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it